Stockscreener 앱 받기
29.56
1.40%
-0.42
전일 마감가:
$29.98
열려 있는:
$30.06
하루 거래량:
9,564
Relative Volume:
1.17
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.05%
1개월 성능:
+9.75%
6개월 성능:
+37.94%
1년 성능:
+6.03%
1일 변동 폭
$29.38
$30.06
1주일 범위
$29.38
$30.06
52주 변동 폭
$20.10
$30.06
Tema Oncology Etf Stock (CANC) Company Profile
CANC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
29.56 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
321.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
653.02 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
656.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
248.10 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
589.50 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf 주식(CANC)의 최신 뉴스
5 Small-cap Biotech ETFs to Watch in 2025 - Nasdaq
What hedge fund moves indicate for Tema ETF Trust Tema Monopolies stockLayoff News & Growth Focused Stock Reports - newser.com
Short Interest in Tema Oncology ETF (NASDAQ:CANC) Increases By 264.8% - Defense World
Tema Etfs LLC Grows Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
How to Take Advantage of moves in (CANC) - news.stocktradersdaily.com
Analysts Predict Tema Oncology ETF to Reach $40, with Stocks CELC, ACLX, and ZYME Showing Significant Upside Potential - AInvest
Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest
Summit Therapeutics Soars 16.5% Amid Regulatory Crossroads and Whale Activity - AInvest
When (CANC) Moves Investors should Listen - news.stocktradersdaily.com
5 Small-cap Biotech ETFs to Watch - Nasdaq
(CANC) Investment Report - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Learn to Evaluate (CANC) using the Charts - news.stocktradersdaily.com
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
(CANC) Technical Pivots with Risk Controls - news.stocktradersdaily.com
(CANC) Investment Analysis and Advice - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - CMC Markets
Pursuing A Better Way To Invest In Life Sciences | Opto Partners - CMC Markets
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
9 Best Biotech ETFs for 2024 - AOL.com
The 5 Best Biotech ETFs of 2024 - ETF.com
11 Best Biotech ETFs To Buy - Yahoo Finance
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema Launches Third Medical-Themed ETF - FA Mag
New ETF Focuses On Obesity, Cardiovascular Disease Treatments - FA Mag
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
NYSE Active ETF Update | October 12, 2023 - NYSE
12 Best Healthcare ETFs To Buy - Yahoo Finance
Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq
Inside Tema ETFs' New Oncology ETF (CANC) - Yahoo Finance
Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews
Tema unveils thematic ETFs on oncology and royalties - ETF Strategy
Thematic ETFs Struggle to Capture Financial Advisors’ Attention - ETF.com
Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire
Getting in on global luxury - ETF Strategy
Tema Oncology Etf (CANC) 재무 분석
Tema Oncology Etf (CANC)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.71%
자본화:
|
볼륨(24시간):